CA125/MUC16 has been shown to inhibit cytolytic responses of human natural killer cells in ovarian cancer, therefore acting as a suppressor of the immune response directed against the ovarian tumors [35,36]. The gene discussed is MUC16; the disease is ovarian cancer.